BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18997617)

  • 1. Expression of Galectin-3, CD138, p16INK4a, and TTF-1 in mucinous bronchioloalveolar adenocarcinoma after Hodgkin lymphoma.
    Al-Salam S; Al-Ashari M
    Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):351-6. PubMed ID: 18997617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases.
    Lau SK; Desrochers MJ; Luthringer DJ
    Mod Pathol; 2002 May; 15(5):538-42. PubMed ID: 12011259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
    Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
    Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies.
    Goldstein NS; Thomas M
    Am J Clin Pathol; 2001 Sep; 116(3):319-25. PubMed ID: 11554157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma].
    Wang CL; Yue DS; Zhang ZF; Zhan ZL; Sun LN
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2350-4. PubMed ID: 18036300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
    Saad RS; Cho P; Silverman JF; Liu Y
    Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin.
    Tsuta K; Ishii G; Nitadori J; Murata Y; Kodama T; Nagai K; Ochiai A
    J Pathol; 2006 May; 209(1):78-87. PubMed ID: 16463270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchioloalveolar differentiation in lung adenocarcinomas.
    Dukić N; Babić B; Eri Z; Zec D; Lovrenski A; Kolarov V
    Bosn J Basic Med Sci; 2011 Nov; 11(4):248-52. PubMed ID: 22117833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: immunohistochemical studies and mutation analysis of the p53 gene.
    Sato K; Ueda Y; Shikata H; Katsuda S
    Pathol Res Pract; 2006; 202(10):751-6. PubMed ID: 16959434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 expression in non-small cell lung carcinoma.
    Puglisi F; Minisini AM; Barbone F; Intersimone D; Aprile G; Puppin C; Damante G; Paron I; Tell G; Piga A; Di Loreto C
    Cancer Lett; 2004 Aug; 212(2):233-9. PubMed ID: 15279903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib.
    Wislez M; Antoine M; Baudrin L; Poulot V; Neuville A; Pradere M; Longchampt E; Isaac-Sibille S; Lebitasy MP; Cadranel J
    Lung Cancer; 2010 May; 68(2):185-91. PubMed ID: 19581016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis and extracellular matrix remodelling in bronchioloalveolar carcinomas: distinctive patterns in mucinous and non-mucinous tumours.
    Guedj N; Couvelard A; Arcangeli G; Dubois S; Thabut G; Lesèche G; Fournier M; Degott C; Groussard O
    Histopathology; 2004 Mar; 44(3):251-6. PubMed ID: 14987229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms.
    Chang YL; Lee YC; Liao WY; Wu CT
    Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
    Rossi G; Cavazza A; Righi L; Sartori G; Bisagni A; Longo L; Pelosi G; Papotti M
    Int J Surg Pathol; 2014 Aug; 22(5):401-7. PubMed ID: 24651909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study.
    Hidaka N; Nagao T; Asoh A; Kondo Y; Nagao K
    Mod Pathol; 1998 Nov; 11(11):1039-45. PubMed ID: 9831199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas.
    Ghazizadeh M; Jin E; Shimizu H; Fujiwara M; Arai S; Ohaki Y; Takemura T; Kawanami O
    Respiration; 2005; 72(1):68-73. PubMed ID: 15753637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype.
    Marchetti A; Buttitta F; Pellegrini S; Chella A; Bertacca G; Filardo A; Tognoni V; Ferreli F; Signorini E; Angeletti CA; Bevilacqua G
    J Pathol; 1996 Jul; 179(3):254-9. PubMed ID: 8774479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
    Awaya H; Takeshima Y; Yamasaki M; Inai K
    Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients).
    Arfaoui-Toumi A; Kria-Ben Mahmoud L; Ben Hmida M; Khalfallah MT; Regaya-Mzabi S; Bouraoui S
    Bull Cancer; 2010 Feb; 97(2):E1-8. PubMed ID: 20080461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.